Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

   247,533      
Direct Value   $43,092,104    

Indirect Value

   $21,938,850      
Total Shares   787,587      
Total Value   $65,030,954      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 12 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-10 4 OE $12.99 $38,970 D/D 3,000 170,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-04 4 OE $12.99 $38,970 D/D 3,000 170,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-07 4 OE $12.99 $38,970 I/I 3,000 16,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-31 4 OE $12.99 $38,970 I/I 3,000 43,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-12-24 4 OE $12.99 $38,970 I/I 3,000 46,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-02 4 OE $12.99 $38,970 I/I 3,000 46,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-09-14 4 OE $9.86 $39,440 D/D 4,000 181,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-09-28 4 OE $9.86 $39,440 D/D 4,000 181,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-04-04 4 OE $14.39 $43,170 D/D 3,000 238,194 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-12-28 4 OE $14.39 $43,170 D/D 3,000 291,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-07 4 OE $14.39 $43,170 D/D 3,000 291,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-10 4 OE $14.39 $43,170 D/D 3,000 291,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-01-22 4 OE $14.39 $43,170 D/D 3,000 291,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-02-21 4 OE $14.39 $43,170 D/D 3,000 291,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-13 4 OE $14.39 $43,170 D/D 3,000 331,701 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-05 4 OE $14.39 $43,170 D/D 3,000 327,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-08 4 OE $14.39 $43,170 D/D 3,000 327,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-26 4 OE $14.39 $43,170 D/D 3,000 329,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-06-25 4 AS $17.65 $44,125 D/D (2,500) 10,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-06-04 4 AS $18.38 $45,962 D/D (2,500) 13,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-30 4 A $51.26 $46,547 D/D 908 252,159 0 -
IMUX Immunic Inc Director   –       •      –    2017-06-13 4 B $3.00 $48,069 D/D 16,000 55,119 2.39 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-07 4 OE $9.86 $49,300 D/D 5,000 118,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-01-26 4 OE $19.75 $49,375 D/D 2,500 47,940 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2010-11-08 4 S $25.78 $51,569 D/D (2,000) 93,567 0 -
  853  Records found
  1   2   3   4   5   6   7   8   9   10   11   12  13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 12 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us